NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
暂无分享，去创建一个
M. Addepalli | S. Doberstein | T. Sweeney | U. Hoch | Jicai Huang | Xiaofeng Liu | P. Kirk | D. Charych | Steve R. Lee | S. Kantak | Thomas K. H. Chang | M. Konakova | Laurie Vanderveen | J. Langowski | Y. Kirksey | Rhoneil Pena | Yujun Wang | Rupesh S. Kanhere | C. Ji | D-S Sheng | P. Sims | C. Ali